Blog Read the latest perspectives from our team of subject matter experts and others Provider Data Has Become InfrastructureEvery health plan is investing in digital transformation, AI, and better member experiences. Yet all of those initiatives ultimately depend on one thing: confidence in the underlying provider data. At… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Drug Development Global Impact KOL Engagement Patient Representation Provider Data Post Industries:Digital Health Health Plans Pharmaceutical & Biotechnology CommercializationDrug DevelopmentKOL EngagementPatient RepresentationProvider DataH1 Closes $58 Million Series B FundingToday, H1 announced a $58 million Series B round of funding to continue working towards our mission of creating a healthier future by connecting parties in the healthcare ecosystem.… Continue reading → Read the article KOL EngagementComplying with MSL RegulationsMedical Science Liaisons (MSLs) are members of the Medical Affairs departments in pharmaceutical companies and have a wide range of responsibilities. An important part of the MSL role is… Continue reading → Read the article KOL EngagementMSL Conduct Dos and Don’tsMedical Science Liaisons (MSLs) are in the field (almost) every day and so are their field-based commercial colleagues, specifically sales representatives. Although they interact with the same people, healthcare… Continue reading → Read the article KOL EngagementPayer Mix: Understanding How Patients Receive Care and Who Pays for itTo find out which healthcare providers (HCPs) are actively treating patients in a therapeutic area, you’ll want access to more than just publication information. To really dig in, you… Continue reading → Read the article KOL EngagementAnnouncing A New Way to Identify KOLs with Claims DataPublications can only get you so far. If your medical affairs team really wants to know who’s actively treating patients in a therapeutic area, you need access to claims data.… Continue reading → Read the article KOL EngagementThe Importance of an Integrated KOL Engagement StrategyBuilding long-term, mutually beneficial relationships with external stakeholders such as physicians, key opinion leaders (KOLs) and other experts is the ultimate goal of medical affairs, specifically medical science liaisons (MSLs).… Continue reading → Read the article«‹15161718192021›»
